Welcome to the international HTA database

Showing [3283 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Components and materials used for total hip replacement: a review of the comparative clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Endovascular therapy for elective and ruptured abdominal aortic aneurysm procedures: a description of utilization trends across Canada
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Knee implant systems: a review of the comparative clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Codeine and acetylsalicylic acid for the management of post-tonsillectomy or adenoidectomy pain: a review of the clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intramuscular oxytocin for the prevention of post-partum hemorrhage outside the hospital: clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antimicrobial ointments for patients undergoing hemodialysis: a review of evidence-based guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Warming of amniofluid: safety
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Advisability of expanding the Québec newborn blood screening program]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Single-use versus single patient-use electric breast pump kits for the prevention of hospital-acquired infections in mothers and newborns: comparative safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Point of care testing compared to laboratory testing for the assessment of white blood cell counts and differentials: a review of the clinical effectiveness, diagnostic precision and accuracy, cost-effectiveness, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of childbirth by midwives: clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Frequency of blood pressure measurements for children and adults: evidence-based guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	External devices for cervical spine immobilization in the pre-hospital setting: clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Removal of intravenous lines following outpatient day procedures: guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ferumoxytol versus other intravenous iron therapies for anemia: a review of the clinical and cost-effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous ketamine for the treatment of pain syndromes: clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nabilone for chronic pain: clinical effectiveness, safety, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nabilone for nausea or vomiting not related to chemotherapy: clinical effectiveness and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Portable bone mineral density scanners for screening and diagnosis of osteoporosis: uses, limitations, and guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of medullary neurostimulators for the treatment of chronic non-cancer pain]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The prevention of blood-borne infection transmission during immunization: clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The use of spine boards in the pre-hospital setting for the stabilization of patients following trauma: a review of the clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The emotional freedom technique for the treatment of post-traumatic stress disorder, depression, or anxiety: clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pentazocine versus short-acting opioids for chronic or acute pain: a review of the clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Protease inhibitor use for chronic hepatitis C infection in prior null responders and recurrent hepatitis C infection post liver transplant: a review of the clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Timing of enoxaparin administration for the prophylaxis of venous thromboembolism: clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Single-bed versus multi-bed rooms for the prevention of hospital acquired infections: clinical effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Precautionary period for the safe handling of excreta or body fluids in patients receiving cytotoxic or antineoplastic therapy: clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism: a review of the clinical and cost-effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retesting patients with sleep apnea: guidelines and recommendations
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hydroxyethyl starch versus other plasma volume expanders: a review of the clinical and cost-effectiveness, and guidelines for use
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Forced air warming units for adults undergoing surgery: clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low molecular weight heparins versus new oral anticoagulants for long-term thrombosis prophylaxis and long-term treatment of DVT and PE: a review of the clinical and cost-effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-acting beta-agonists and inhaled corticosteroids for treatment of chronic obstructive pulmonary disease: a review of the clinical efficacy and cost-effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sleep medications for adults diagnosed with insomnia: clinical evidence and harms
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Summary of the exploration of the scientific literature on the effects of prostate cancer screening decision aids for the expert panel of the Collège des médecins du Québec]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Traumatic and non-traumatic spinal cord injury: a comparative analysis of the characteristics and organization of rehabilitation care and services in Québec]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of prolotherapy in the treatment of chronic musculoskeletal conditions]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening for sexually transmitted infections: a review of guidelines
2013	HTA Unit, University of Calgary	Use of Oncotype DX for guiding adjuvant chemotherapy decisions in early stage invasive breast cancer patients in Alberta
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Notice on the reimbursement of proton pump inhibitors]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Brentuximab for refractory CD30+ Hodgkin's lymphoma: clinical and cost-effectiveness
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Treatment and follow-up of children with sickle cell disease (SCD)]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Administration of anesthesia by anesthesiologists versus non-physicians for patients undergoing cataract surgery: clinical effectiveness, cost-effectiveness, and guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Systemic hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Standing tables for adults with cerebral palsy: a review of the clinical evidence
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Overview of dabigatran usage among people insured by the public prescription drug insurance plan]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tools and devices for the management of dementia in older adults: review of evidence-based guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Overview of the drugs used by children and adolescents diagnosed with autism spectrum disorder who are covered by the Public Prescription Drug Insurance Plan]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Beta human chorionic gonadotropin test for detection of early pregnancy: clinical effectiveness, cost-effectiveness, and guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Falls in patients living in health care facilities (short- and long-term care)]
2013	Institute of Health Economics (IHE)	Islet transplantation for the treatment of type 1 diabetes [update]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of intrathecal pumps for the treatment of chronic non-cancer pain]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interventions used to determine the appropriate patient populations for cataract surgery: a review of the clinical evidence and guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Self-monitoring of blood glucose in adult patients with Type 2 Diabetes not using insulin]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Sublingual immunotherapy for respiratory allergies]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antimicrobial drapes for the reduction of surgical site infection: clinical effectiveness
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Efficiency of short-term social and psychological therapies: Systematic review]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Compression bandage measurement devices for the use in adult patients with chronic venous insufficiency: clinical effectiveness
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Current strategies for optimizing the relevance of laboratory test prescription: a review of Canadian and international experiences]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Techniques for renal biopsy: guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Patient-based funding: a literature review of experiences in other countries]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Peripherally Inserted Central Catheters (PICCs) for adult and pediatric patients: a review of clinical evidence
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Notice regarding field trauma triage criteria]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin D supplementation in long-term care residents: clinical evidence and guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Effectiveness of short term social and psychological interventions: a systematic review]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	High-sensitivity cardiac troponin for the rapid diagnosis of acute coronary syndrome in the emergency department: a clinical and cost-effectiveness evaluation
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Recommendations for the use of troponin assays for rapid diagnosis of acute coronary syndrome in the emergency department
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cataract surgery performed in settings other than hospital operating rooms: clinical effectiveness, cost-effectiveness, and guidelines
2013	Technology Assessment at SickKids (TASK)	Thiopurine dosing using thiopurine methyltransferase status: a systematic review of clinical guidance
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fecal bacteriotherapy for patients with recurrent C. difficile: clinical effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Techniques for the management of temporary epicardial pacemaker leads: clinical evidence, safety, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tricyclic antidepressants, clonidine, venlafaxine, and modafinil for the treatment of attention-deficit/hyperactivity disorder in adults: a review of the clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Probiotics in infants: clinical effectiveness, safety and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Rasburicase for adults with acute tumor lysis syndrome: a review of clinical and cost effectiveness and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Patient lifts and transfer equipment for preventing pressure ulcers: a review of clinical and cost-effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Esophageal doppler ultrasound-based cardiac output monitoring for adults undergoing surgery: a review of clinical and cost-effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness — an update
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug therapies for immunosuppression in adult patients following islet cell transplantation for the treatment of diabetes: clinical and cost-effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	JC virus antibody testing for patients with MS: a review of the diagnostic accuracy and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Treatment of patients with multiple sclerosis: a review of guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tinzaparin versus dalteparin or enoxaparin for the treatment of venous thromboembolism in adults: safety and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Techniques to improve the use of diagnostic laboratory test ordering: clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antibiotic prophylaxis for patients with cardiac or orthopedic implants undergoing dental procedures: a review of the clinical effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Biologic response modifier agents as first-line treatment for patients with rheumatoid arthritis: a review of the clinical efficacy, cost-effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bone morphogenetic proteins for use in spinal surgery and long bone trauma surgery: a review of the clinical effectiveness and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fecal management systems for hospitalized adult patients: comparative clinical effectiveness and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Osteostimulative bone graft substitutes or demineralized bone matrix preparations for use in spinal Surgery and long bone trauma surgery: clinical effectiveness and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fusidic acid for ophthalmic infections: a review of clinical and cost effectiveness and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The timing of prophylactic antibiotics for surgery: a review of the clinical Evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Computed tomography guided versus ultrasound guided renal biopsy: comparative evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prioritizing patients undergoing non-urgent, medically necessary cosmetic surgical procedures: clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Codeine compared with other opioids for pain relief in pediatric patients: comparative clinical effectiveness, safety, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Meperidine to relieve shivering or bladder spasm: clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Inhaled tobramycin versus intravenous tobramycin for patients with cystic fibrosis: a review of the clinical effectiveness, cost effectiveness, and guidelines
2013	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Prevention of nephropathy by iodinated contrast media during a radiological intervention]